Aldehydes accumulate in inflammation, during myocardial infarction and have been associated with pain symptoms. One pathway of aldehyde detoxification is the conjugation with carnosine. A 3-methylpyridinium carnosine adduct from the reaction of carnosine and acrolein was characterized using extensive spectroscopic measurements. The adduct with urinary concentrations of 1.82 ± 0.68 nmol/mg of creatinine is one of the most abundant acrolein metabolites in urine and opens promising therapeutic strategies for carnosine.
. Carnosine is found in high concentrations in skeletal muscle as well as in the central nervous system 5 . However, its physiological function is still not fully understood. Though it is widely accepted that carnosine plays an important role as an intracellular buffer 8 , carnosine has also been described as having physiological roles as an anticonvulsant 9 , a quencher of metals 10 and a promoter of anti-senescence 11 . Carnosine also has the ability to react with α , β -unsaturated aldehydes, including HNE and ACR 5 . In addition, as reviewed by Vistoli and co-workers 12 , carnosine conjugation has been suggested as a mechanism involved in the prevention, inhibition and reversal of the formation of advanced glycoxidation (AGEs) and lipid-oxidation end products (ALEs). In fact, the treatment of obese Zucker rats with carnosine for 24 weeks significantly reduced the incidence of obese-related diseases and prevented the development of dyslipidemia, hypertension and renal injury 13 . Michael adducts formed from the reaction of carnosine with HNE and their corresponding metabolites were identified in rat urine, suggesting that the detoxifying reaction of carnosine occurs in vivo 14 and that carnosine by-products can be used as possible biomarkers of lipid-derived carbonyl stress. Conjugates of carnosine and aldehydes are excreted in urine as carnosine-propanols 6 . Acrolein also forms covalent conjugates with other related histidyl dipeptides, indicating that biological histidyl dipeptides may exert a general detoxifying function by reacting with unsaturated aldehydes 6 . These studies are in agreement with other works that suggest that carnosine, in addition to acting as an intracellular buffer, behaves similarly to GSH in that it may function as a cytosolic scavenger 5 . Herein, we report the complete characterization of a new product arising from the reaction of carnosine and acrolein. In addition, the biological formation of the CAR-ACR adduct was demonstrated by the detection and quantification of this product in human urinary samples through the development and validation of a new, sensitive method using on-line reverse-phase HPLC coupled with an electrospray ion-trap tandem mass spectrometer (ESI + HPLC-MS/MS). This system allowed for the simultaneous quantitative determination of 3-methylpyridinium carnosine (CAR-ACR), L-carnosine-4-hydroxy-2-hexenal (CAR-HHE) and L-carnosine-4-hydroxy-trans-2-nonenal (CAR-HNE) adducts in human urinary samples from non-smoking adults. The work was approved by the Human Ethics Committee of the Institute of Biomedical Sciences of the University of São Paulo. Methods were carried out in accordance with the approved guidelines (Supplementary Methods). Written informed consent was obtained from every urine donor.
The synthesis of the CAR-ACR adduct was performed as described by Carini et al. 15 , with modifications. L-Carnosine (45 μ mol) was incubated with acrolein (15 μ mol) in 1 mL of phosphate buffer, 10 mM, pH 7.0. The solution was mixed at 1000 rpm at 37 °C for 24 h. The adducts were analyzed using an HPLC LC 20 series system (Shimadzu, Kyoto, Japan) coupled to an Amazon Speed electrospray ion-trap mass spectrometer (Bruker Daltonics, Bremen, Germany). A Luna NH 2 analytical column (150 mm × 3.0 mm i.d., 5 μ m, 100 Å, Phenomenex, Torrance, CA, USA) at 25 °C and a flow rate of 0.6 mL/min was used for the analyses. The purifications were performed with a Luna NH 2 semi-preparative column (250 mm × 10 mm i.d., 100 Å, 10 μ m of particle size Phenomenex, Torrance, CA. USA) at 25 °C and a flow rate of 5.5 mL/min. The HPLC mobile phase consisted of 5 mM ammonium formate in water (A) and acetonitrile (B). The analysis and purification of the adduct was performed using a linear elution gradient: 95 to 20% B from 0-25 min, 20 to 5% B from 25-50 min, and 5 to 95% B from 50-60 min to re-equilibrate the column. The fraction eluting at 10 min with m/z = 303 was collected, lyophilized and kept at − 20 °C (Supplementary Fig. 1 Direct infusion-Ion-Trap MS and ESI-Ion-Trap MS n were used for the analysis of the products arising from the reaction of carnosine with HHE and HNE ( Supplementary Figs 2 and 3 ). The reactions gave rise to the same main products described before [16] [17] [18] . The molar extinction coefficient of the products were determined from UV measurements as ε 260 = 2.5037 × 10 2 M −1 cm −1 for CAR-HHE and ε 266 = 1.9212 × 10 2 M −1 .cm −1 for CAR-HNE ( Supplementary Fig. 4 ). The MS n and NMR analysis of the product with m/z = 303 from the reaction used to synthesize CAR-ACR suggested a different structure from that reported in the literature, thus prompting a careful investigation. Previous studies have shown that in aqueous solution, carnosine initially reacts with unsaturated aldehydes to form a Schiff base, which is followed by a Michael addition, cyclization reaction, and the formation of a hemiacetal product 16 . Alternatively, a pyrrole ring 14 or a picoline ring 18 may be formed. By applying these mechanisms to the reaction of carnosine with ACR and matching the proposed products with the results of the HPLC-MS/MS (Fig. 1) and 1 H and 13 Figs 5 and 6 ) experiments, it became clear that the product yielded in our experiments was the one containing a β -picoline moiety. Its exact mass was determined as m/z = 303.1415 (Fig. 1) . This result is compatible with the molecular formula C 15 H 19 N 4 O 3 (Compass Isotope Pattern, Bruker Daltonics, Bremen, Germany). The NMR results showed three hydrogens bound to carbons. Each hydrogen was coupled to the next hydrogen at 8.9, 7.1 and 7.4 ppm, respectively, with apparent J values ca. 6-8 Hz. A further lone hydrogen indicated by an apparent singlet at 9.0 ppm and a methyl group indicated by an apparent singlet at 2.0 ppm, when taken together, suggested a β -picolinium moiety. Furthermore, two hydrogens that were not bound to carbon were indicated by peaks at 6.3 and 6.5 ppm, suggesting that two of the three nitrogen atoms of the molecule were bound to hydrogens (proven by the disappearance of these signals when the compound was diluted in D 2 O-data not shown).
C NMR (Supplementary
These results led us to conclude that the structure of the product of the reaction between carnosine and acrolein with m/z = 303 contained a β -picolinium ring (Fig. 2) corresponding to structure III (Supplementary Fig. 7) . A further, more thorough analysis of all of the NMR spectral data supports well this conclusion. Additionally, the UV spectrum of the purified product showed an absorbance at 260 nm, which is also consistent with a picoline chromophore (ε 266 = 5.18796 × 10 2 M −1 cm −1 - Supplementary Fig. 4C ). Thus, our data indicated that similar to the reaction of carnosine with HNE 15, 17 , the reaction of carnosine with ACR first involves the binding of the distal amino group of carnosine with ACR to form a Schiff base, which then undergoes dehydration and cyclization via Michael addition into an imidazole ring. This results in the formation of the unstable intermediate compound at m/z = 265, which can react with another acrolein molecule. A cyclization reaction results in the formation of the final product (1-(3-{[1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino}-3-oxopropyl)-N-3-methylpyridinium at m/z = 303 (Fig. 2) . This compound is similar to the one described by Furahata et al. 19 , which resulted from the reaction between lysine and acrolein and is suggested to be a potent carcinogen. This product is also similar to various other products formed in the reaction of carnosine with unsaturated aldehydes 6 , though here, we observed a different structure from the one reported before 15, 16 . A sensitive methodology based on ESI + HPLC-MS/MS ( Supplementary Fig. 8 ) was developed for the accurate quantification of CAR-ACR, CAR-HHE and CAR-HNE adducts in human urinary samples from non-smoking adults. Supplementary Fig. 9 shows a representative chromatogram of the analysis. The method allowed for the sensitive quantification of 10 pmol of CAR-HHE and 1 pmol of CAR-ACR and CAR-HNE (signal/noise > 6) in urine, with 98% accuracy and variation coefficients (VC) of 10% ( Supplementary Fig. 10 ).
In the urine samples from men, concentrations of 1.82 ± 0.68, 2.30 ± 1.45, 1.28 ± 0.46 nmol/mg of creatinine were found for CAR-ACR, CAR-HHE and CAR-HNE, respectively (Fig. 3) . In a recent work, Baba et al. 6 showed that CAR-aldehyde adducts are also metabolized by aldose reductase to alcohol and excreted in urine. It was discussed that the CAR-linked pathway was responsible for ca. 15% of all metabolized ACR. Our data showed that the product 3-methylpyridinium carnosine, with concentrations of approximately 1.82 ± 0.68 nmol/mg of creatinine, is one of the most abundant acrolein metabolites in human urine. This indicates that the carnosine-linked pathway may play an important role in the cellular detoxification of aldehydes 20 . Herein we have used MS-MSn, and NMR analysis to elucidate the structure of a 3-methylpyridinium carnosine (m/z 303) from the reaction of carnosine and acrolein. We have also developed a methodology for the simultaneous quantification of carnosine adducts in urine ( Supplementary Fig. 11 is a summary of the products resulting from the reactions of carnosine with acrolein, HHE and HNE). Our results show that CAR-ACR, CAR-HHE and CAR-HNE are present in urine samples from adult humans and support the hypothesis that histidine-containing peptides are important for the metabolism of unsaturated aldehydes. A recent study has demonstrated that activation of aldehyde dehydrogenase-2 (ALDH2), which metabolizes many aldehydes, reduces nociception in two rodent models suggesting an associative role of aldehyde adducts in pain symptoms 21 . Thus the use of carnosine or the combination of carnosine with ALDH2 activators may be a promising therapeutic strategy in pain relieve or in pathologies associated with reactive aldehyde accumulation as inflammation and ischemic injury.
